Article Notes

• Hide
  • Pearls
  • Summaries
  • Comments

pearl
1
Patient satisfaction with anaesthesia is unchanged by post-operative anaesthetist visit.
Saal D, Heidegger T, Nuebling M et al. Does a postoperative visit increase patient satisfaction with anaesthesia care? Br J Anaesth. 2011 Nov 1;107(5):703-9.
  Daniel Jolley
comment
1
See the more recent 2022 article, Return to exercise post-COVID-19 infection: A pragmatic approach in mid-2022, which also sets out a graduated return to exercise, though is perhaps even more pragmatic.
Jewson J, McNamara A, Fitzpatrick J. Life after COVID-19: The importance of a safe return to physical activity. Aust J Gen Pract. 2020 Nov 25; 49.
  Daniel Jolley
pearl
1
After recovering from mild COVID infection with minimal or no symptoms, most recreational athletes can gradually increase exercise intensity over six days, returning to normal activity on day 7 if graduation is well tolerated.
Hughes DC, Orchard JW, Partridge EM et al. Return to exercise post-COVID-19 infection: A pragmatic approach in mid-2022. J Sci Med Sport. 2022 Jul 1; 25 (7): 544-547.
  Daniel Jolley
pearl
0
After COVID recovery, most vaccinated elite athletes achieve pre-morbid fitness levels by day 7-14.
Hughes DC, Orchard JW, Partridge EM et al. Return to exercise post-COVID-19 infection: A pragmatic approach in mid-2022. J Sci Med Sport. 2022 Jul 1; 25 (7): 544-547.
  Daniel Jolley
pearl
1
Nuvaxoid is safe and 90% effective against the Alpha (B.1.1.7) SARS-CoV-2 variant.
Dunkle LM, Kotloff KL, Gay CL et al. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N. Engl. J. Med. 2022 Feb 10; 386 (6): 531543531-543.
  Daniel Jolley
pearl
0
Nuvaxoid is safe and 90% effective against the Alpha (B.1.1.7) SARS-CoV-2 variant.
Heath PT, Galiza EP, Baxter DN et al. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine. N. Engl. J. Med. 2021 Sep 23; 385 (13): 117211831172-1183.
  Daniel Jolley
pearl
1
Statin use is associated with decreased COVID mortality.
AFMZ Zein, Sulistiyana CS, Khasanah U et al. Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts. Postgrad Med J. 2022 Jul 1; 98 (1161): 503508503-508.
  Daniel Jolley
comment
0
The usual 'correlation is not causation' qualifier is very necessary here. Perhaps doubly-so because this is a meta-analysis using pooled data of over 1 million people.
It's completely possible that someone who chooses to receive an influenza vaccine is also someone who makes more cautious health decisions and is more risk-averse, reducing their COVID exposure risk. The vaccinated are also more likely to be from better health-serviced locations and probably from higher socio-economic groups.
Still, interesting association nonetheless.
Su W, Wang H, Sun C et al. The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis. Am J Prev Med. 2022 Jul 1; 63 (1): 121-130.
  Daniel Jolley
pearl
1
Influenza immunisation may be associated with reduced risk of COVID infection (RR 95% CI 0.76-0.90).
Su W, Wang H, Sun C et al. The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis. Am J Prev Med. 2022 Jul 1; 63 (1): 121-130.
  Daniel Jolley
pearl
1
Three-panel flat-fold N95 masks performed best for both fit test (96% pass) and wearer comfort and usability.
Ng I, Kave B, Begg F et al. N95 respirators: quantitative fit test pass rates and usability and comfort assessment by health care workers. Med. J. Aust. 2022 Jul 18; 217 (2): 88-93.
  Daniel Jolley